India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore.India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore
Geopolitics, crude risk and the IT conundrum: Sridhar Sivaram on why investors may need to stay selective
Geopolitical tensions in West Asia are creating market uncertainty, impacting energy supplies and capital flows. While Indian equities have shown resilience, prolonged conflict could significantly